NCI Navigant Consulting Inc.

Navigant Appoints Managing Directors to Healthcare Segment

Navigant (NYSE: NCI) today announced that Milind Pawar and Warren Skea, Ph.D., have joined the firm as managing directors in its Healthcare segment.

In their roles, Pawar and Skea will provide advice to executives and boards with hospitals and health systems, physician enterprises, and payers on creating operating models and high-performing networks that drive sustainable results. Pawar will lead Navigant Healthcare’s corporate services solutions, while Skea will join the firm’s strategic practice.

“For any healthcare organization, success today requires re-evaluating and right-sizing strategic investments that have been made in growth, technology, and population health,” said David Burik, managing director and leader of Navigant’s payer/provider consulting division. “Both Milind and Warren have proven change management and performance improvement track records, based on decades of experience working directly with executives on multifunctional initiatives that achieve quantifiable strategic and operational outcomes.”

Recognized for leading transformative engagements that optimize performance, Pawar brings deep knowledge of the strategic and operational challenges faced by providers, payers, and pharmacy benefit manager (PBM) leadership. He most recently served as a managing director for Accenture, where he led cross-functional programs that realized more than $500 million in annual savings. He also has experience helping providers develop new operating models and enhance the customer and employee experience, establishing post-merger plans for integration of specialty PBMs, and architecting growth strategies for Medicaid managed care plans. Pawar was also a senior project manager at global design and strategy firm frog, where he successfully brought more than a dozen consumer products to market.

Skea comes to Navigant from PwC, where he was a partner. In that role, Skea led business development teams and large strategic engagements for provider, payer, pharmaceutical, and medical device clients. Prior to that, he rose to prominence as national director of quality improvement initiatives for the American Heart Association (AHA), where he helped develop and implement processes, policies, and procedures for the AHA’s hospital-based quality improvement program, Get with the Guidelines. Skea’s work has been published in major publications, and presented at national and international conferences, covering such topics as value-based care, health policy, organizational culture, and strategic transformation.

Navigant’s Healthcare segment is composed of consultants, former provider administrators, clinicians, and other experts with decades of strategy, operational/clinical consulting, managed services, revenue cycle management, and outsourcing experience. Professionals collaborate with hospitals and health systems, physician enterprises, payers, government, and life sciences entities, providing strategic, performance improvement, and business process management solutions that help them meet quality and financial goals.

About Navigant

Navigant Consulting, Inc. (NYSE: NCI) is a specialized, global professional services firm that helps clients take control of their future. Navigant’s professionals apply deep industry knowledge, substantive technical expertise, and an enterprising approach to help clients build, manage, and/or protect their business interests. With a focus on markets and clients facing transformational change and significant regulatory or legal pressures, the firm primarily serves clients in the healthcare, energy, and financial services industries. Across a range of advisory, consulting, outsourcing, and technology/analytics services, Navigant’s practitioners bring sharp insight that pinpoints opportunities and delivers powerful results. More information about Navigant can be found at navigant.com.

EN
01/02/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Navigant Consulting Inc.

NAVIGANT CNSL.INCO. is slightly downgraded to Slightly Positive due to...

The independent financial analyst theScreener just slightly lowered the general evaluation of NAVIGANT CNSL.INCO. (US), active in the Business Support Services industry. As regards its fundamental valuation, the title confirms its rating of 3 out of 4 stars while its market behaviour remains unchanged and can be qualified as defensive. However, a marginally less favourable environment forces theScreener to downgrade slightly the title, which now shows an overall rating of Slightly Positive. As o...

Valens Research
  • Valens Research

Valens Equity Insights and Inflections - 2019 04 17

BZH currently trades near recent lows relative to UAFRS-based (Uniform) Earnings, with a 6.7x Uniform P/E. At these levels, the market is pricing in expectations for Uniform ROA to decline from 11% in 2018 to 5% in 2023, accompanied by 1% Uniform Asset growth going forward. However, analysts have bullish expectations, projecting Uniform ROA to expand to 13% through 2020, accompanied by 3% Uniform Asset shrinkage. Moreover, management is confident in structural plan options, their balanced growth...

Valens Research
  • Valens Research

NCI - Embedded Expectations Analysis - 2019 04 11

Navigant Consulting Inc. (NCI:USA) currently trades below recent averages relative to UAFRS-based (Uniform) Earnings, with a 15.6x Uniform P/E. Even at these levels, the market is pricing in expectations for Uniform ROA to improve from a low of 9% in 2018 to 11% in 2023. Specifically, markets appear optimistic about the competitive position of the firm's remaining industry segments and the potential to drive top-line growth. However, they may be skeptical of the benefits of a simplified portfol...

MarketLine Department
  • MarketLine Department

ICF International, Inc. - Mergers & Acquisitions (M&A), Partnerships &...

Summary Marketline's ICF International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by ICF International, Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of th...

2 directors sold after exercising options/sold

Two Directors at Navigant Consulting Inc sold after exercising options/sold 49,598 shares at between 24.120USD and 24.240USD. The significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch